Purchase Order 75D30124P19018
Award Date 6/21/24
Potential Completion Date 4/4/25
Potential Value $224K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $236,726.60 contract is for a service agreement to provide the CDC with Illumina's advanced sequencing instruments, reagents, consumables, and bioinformatics software. The contract does not have a set-aside designation and has an ultimate completion date of August 31, 2026....
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the provision of Genomic Sequencing Kits with a ceiling value of $170,641.14 and a performance period ending on August 28, 2024. The contract does not utilize a set-aside designation. Illumina is the prime contractor and has been awarded multiple federal contracts...
- This is a $18,768.00 firm fixed-price purchase order awarded to Illumina, Inc., a for-profit manufacturer of genetic sequencing and genomic analysis technologies, by the Centers for Disease Control and Prevention (CDC) on July 14, 2019. The contract, which has an ultimate completion date of September 29, 2024, is for the provision of equipment maintenance services. The contract is not set aside for any specific business category. Illumina holds two significant federal Indefinite Delivery...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc. for the supply of lab supplies. The contract has a ceiling value of $97,152 and runs through February 28, 2017. The contract is not set aside for any special business designation. Illumina is a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. Through past federal contract awards, Illumina has provided a range of...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to facilitate the relocation of equipment to accommodate COVID-19 (CORVD) operations. The $20,092.00 contract has an ultimate completion date of August 1, 2024. Illumina has a history of providing sequencing systems and associated services to support genomic research and diagnostics across various...
- This firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Illumina, Inc., a for-profit manufacturer of sequencing and array-based genomic analysis solutions. The $98,094.00 contract is for the provision of laboratory equipment, with no set-aside designation. Based on Illumina's past federal contract work, the equipment is likely to include Next-Generation DNA sequencing systems, reagents, and related...
- The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
- This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $20,400.00, is for the provision of ILLUMINA - AMPLISEQ products and services, with a period of performance through September 30, 2024. The contract has no set-aside designation. Illumina has a history of providing sequencing equipment and consumables to support...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $85,056.40 contract is for the delivery of laboratory reagents, with an ultimate completion date of July 31, 2022. The contract does not have a set-aside designation. Illumina has previously received federal prime contract and subcontract awards from agencies like the National...
- This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments and reagents. The $83,968.67 contract is for the provision of unspecified goods and services, with no set-aside designation. Illumina has a history of providing sequencing systems, consumables, and related services to federal agencies like the NIH, USDA, and VA for genomic research and diagnostic applications....